The review by Drs. Massey and Wald, published in this issue of Digestive Diseases and Sciences [1], is a timely reminder regarding the availability and pitfalls of the use of noninvasive breath tests for the identification of small intestinal bacterial overgrowth (SIBO) in patients with nonspecific gastrointestinal symptoms. Massey and Wald have provided the evidence for their recommendation to strongly discourage performance of the lactulose hydrogen breath test due to the confounding influence of accelerated orocecal transit, including false positives manifesting as elevations of either breath hydrogen or methane. The authors identified important principles and approaches regarding the diagnosis of SIBO in Table 1 of their article. We provide here a practical format that can be used in the clinical setting or in the laboratory where the test is performed, as shown in the algorithm in Fig. 1.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.